Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in Cosmo’s Vision 2030, strengthening the Company’s foundations for scalable, innovation-driven growth across AI-enabled ...

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying ...

Harmattan AI's $200 million Series B led by Dassault Aviation Paris - Saint-Cloud, France, January 12, 2026 - Dassault Aviation and Harmattan AI today announced a strategic partnership to accelerate ...

VALLOUREC WINS A SIGNIFICANT CONTRACT WITH SHELL IN BRAZIL Meudon (France), January 12, 2026 - Vallourec, a world leader in premium seamless tubular solutions, announces that it has secured a ...